Literature DB >> 14747559

Identification of antigenic regions of duck hepatitis B virus core protein with antibodies elicited by DNA immunization and chronic infection.

A Thermet1, M Robaczewska, C Rollier, O Hantz, C Trepo, G Deleage, L Cova.   

Abstract

The induction of humoral response in ducks by DNA-based immunization against duck hepatitis B virus (DHBV) core protein (DHBc) was investigated. In addition, the amino acid specificity of the induced response was compared by using peptide scanning to that elicited either by protein immunization or during chronic DHBV infection. Immunization of ducks with a plasmid expressing DHBc protein led to the induction of a long-lasting antibody response able to specifically recognize viral protein in chronically infected duck livers. Peptide scanning analysis of anti-DHBc response induced during chronic DHBV infection allowed us to identify six major antigenic regions (AR1 to AR6). The reactivity spectrum of duck sera elicited by protein immunization appeared narrower and was restricted to only four of these antigenic regions in spite of higher anti-DHBc antibody titers. Interestingly, anti-DHBc antibodies induced by DNA-based immunization recognized five of six antigenic regions, and the epitope pattern was broader and more closely related to that observed in chronic viral infections. To gain more insight into the location of antigenic regions, we built a three-dimensional (3-D) model of DHBc protein based on human and duck core sequence alignment data and the HBc 3-D crystal structure. The results suggest that two identified antigenic regions (AR2, amino acids [aa] (64)T-P(84), and AR5, aa (183)A-R(210)) are located at positions on the protein surface equivalent to those of the two HBc major epitopes. Moreover, we identified another antigenic region (AR3, aa (99)I-I(112)) that was recognized by all sera from chronically infected, DNA- or protein-immunized ducks within the large 45-aa insertion in DHBc protein, suggesting that this region, which lacks HBc, is externally exposed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14747559      PMCID: PMC369491          DOI: 10.1128/jvi.78.4.1945-1953.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  36 in total

1.  The crystal structure of the human hepatitis B virus capsid.

Authors:  S A Wynne; R A Crowther; A G Leslie
Journal:  Mol Cell       Date:  1999-06       Impact factor: 17.970

2.  Geno3D: automatic comparative molecular modelling of protein.

Authors:  Christophe Combet; Martin Jambon; Gilbert Deléage; Christophe Geourjon
Journal:  Bioinformatics       Date:  2002-01       Impact factor: 6.937

Review 3.  Gene vaccines.

Authors:  Indresh K Srivastava; Margaret A Liu
Journal:  Ann Intern Med       Date:  2003-04-01       Impact factor: 25.391

4.  Peptide mapping of neutralizing and nonneutralizing epitopes of duck hepatitis B virus pre-S polypeptide.

Authors:  S Yuasa; R C Cheung; Q Pham; W S Robinson; P L Marion
Journal:  Virology       Date:  1991-03       Impact factor: 3.616

5.  Characterization of the major duck hepatitis B virus core particle protein.

Authors:  J Pugh; A Zweidler; J Summers
Journal:  J Virol       Date:  1989-03       Impact factor: 5.103

6.  Strategies for epitope analysis using peptide synthesis.

Authors:  H M Geysen; S J Rodda; T J Mason; G Tribbick; P G Schoofs
Journal:  J Immunol Methods       Date:  1987-09-24       Impact factor: 2.303

7.  Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid.

Authors:  H M Geysen; R H Meloen; S J Barteling
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

8.  Characterisation of a linear binding site for a monoclonal antibody to hepatitis B core antigen.

Authors:  M Sällberg; U Rudén; L O Magnius; H P Harthus; M Noah; B Wahren
Journal:  J Med Virol       Date:  1991-04       Impact factor: 2.327

9.  Antiviral effect of adefovir in combination with a DNA vaccine in the duck hepatitis B virus infection model.

Authors:  Franck Le Guerhier; Alexandre Thermet; Sylvianne Guerret; Michèle Chevallier; Catherine Jamard; Craig S Gibbs; Christian Trépo; Lucyna Cova; Fabien Zoulim
Journal:  J Hepatol       Date:  2003-03       Impact factor: 25.083

10.  Nucleotide sequence of a cloned duck hepatitis B virus genome: comparison with woodchuck and human hepatitis B virus sequences.

Authors:  E Mandart; A Kay; F Galibert
Journal:  J Virol       Date:  1984-03       Impact factor: 5.103

View more
  8 in total

Review 1.  Immunoglobulins of the non-galliform birds: antibody expression and repertoire in the duck.

Authors:  Mats L Lundqvist; Darlene L Middleton; Cynthia Radford; Gregory W Warr; Katharine E Magor
Journal:  Dev Comp Immunol       Date:  2006       Impact factor: 3.636

2.  Bicistronic woodchuck hepatitis virus core and gamma interferon DNA vaccine can protect from hepatitis but does not elicit sterilizing antiviral immunity.

Authors:  Jinguo Wang; Shashi A Gujar; Lucyna Cova; Tomasz I Michalak
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

3.  Snow goose hepatitis B virus (SGHBV) envelope and capsid proteins independently contribute to the ability of SGHBV to package capsids containing single-stranded DNA in virions.

Authors:  Natalie Greco; Michael H Hayes; Daniel D Loeb
Journal:  J Virol       Date:  2014-07-02       Impact factor: 5.103

4.  Monoclonal antibodies providing topological information on the duck hepatitis B virus core protein and avihepadnaviral nucleocapsid structure.

Authors:  Jolanta Vorreiter; Immanuel Leifer; Christine Rösler; Ludmila Jackevica; Paul Pumpens; Michael Nassal
Journal:  J Virol       Date:  2007-09-19       Impact factor: 5.103

5.  A structural model for duck hepatitis B virus core protein derived by extensive mutagenesis.

Authors:  Michael Nassal; Immanuel Leifer; Ida Wingert; Kai Dallmeier; Simone Prinz; Jolanta Vorreiter
Journal:  J Virol       Date:  2007-09-19       Impact factor: 5.103

6.  Potent inhibition of late stages of hepadnavirus replication by a modified cell penetrating peptide.

Authors:  Fabien Abdul; Bénédicte Ndeboko; Thierry Buronfosse; Fabien Zoulim; Michael Kann; Peter E Nielsen; Lucyna Cova
Journal:  PLoS One       Date:  2012-11-16       Impact factor: 3.240

7.  A recombinant multiepitope protein for hepatitis B diagnosis.

Authors:  Marilen Queiroz de Souza; Alexsandro Sobreira Galdino; José Carlos dos Santos; Marcus Vinicius Soares; Yanna C de Nóbrega; Alice da Cunha Morales Alvares; Sonia Maria de Freitas; Fernando Araripe Gonçalves Torres; Maria Sueli Soares Felipe
Journal:  Biomed Res Int       Date:  2013-11-05       Impact factor: 3.411

Review 8.  Immunoglobulin Y for Potential Diagnostic and Therapeutic Applications in Infectious Diseases.

Authors:  Lucia Lee; Kate Samardzic; Michael Wallach; Lyn R Frumkin; Daria Mochly-Rosen
Journal:  Front Immunol       Date:  2021-06-09       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.